Journal
NEUROCHEMICAL RESEARCH
Volume 28, Issue 11, Pages 1705-1713Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1023/A:1026065122854
Keywords
neurodegeneration; Alzheimer's disease; amyloid beta-protein; synaptic plasticity; proteolysis; therapeutics
Categories
Ask authors/readers for more resources
Deciphering the molecular basis of synaptic dysfunction in Alzheimer's disease (AD) has engaged the attention of scientists with diverse backgrounds and interests. The synthesis of experimental findings from neuropathology, biochemistry, genetics, animal modeling and even immunology, has provided a plausible model for the pathogenesis of the disorder. While not universally accepted, the so-called amyloid (or Abeta) hypothesis of AD is well supported scientifically and predicts several specific targets for therapeutic intervention. Some of these are now reaching the clinic, providing the final and most important test for this hypothetical mechanism of disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available